Mostrando 10 resultados de: 14
Publisher
Archives of Osteoporosis(1)
Bioengineering(1)
Bone(1)
Brain Research(1)
Current Pharmaceutical Design(1)
Área temáticas
Fisiología humana(8)
Enfermedades(6)
Farmacología y terapéutica(6)
Cirugía y especialidades médicas afines(4)
Medicina y salud(4)
Objetivos de Desarrollo Sostenible
ODS 3: Salud y bienestar(14)
ODS 9: Industria, innovación e infraestructura(7)
ODS 4: Educación de calidad(6)
ODS 2: Hambre cero(1)
A manufacturing approach to functional biomimetic three-dimensional-printed bone implants
ArticleAbstract: Orthopedic surgeons frequently face the problem of selecting adequate implants that fulfill certainPalabras claves:bone reconstruction, Bone scaffolds, Implants, orthopedics, three-dimensional printingAutores:Carlos G. Helguero, David Edward Komatsu, Emilio A. Ramírez, Jorge Luis Amaya Rivas, Kao I., Pentyala S.N.Fuentes:googlescopusChronic oral methylphenidate treatment in adolescent rats promotes dose-dependent effects on NMDA receptor binding
ArticleAbstract: Aim: Examine the effects of chronic oral Methylphenidate (MP) treatment on the N-Methyl-D-aspartic aPalabras claves:ADOLESCENCE, methylphenidate, NMDA, ritalinAutores:David Edward Komatsu, Delis F., Hadjiargyrou M., Hamilton J., Jalloh K., Roeder N., Thanos P.K.Fuentes:scopusChronic oral methylphenidate treatment reversibly increases striatal dopamine transporter and dopamine type 1 receptor binding in rats
ArticleAbstract: Previously, we created an 8-h limited-access dual bottle drinking paradigm to deliver methylphenidatPalabras claves:dopamine, methylphenidate, Psychostimulant, Reward deficiency syndrome, reward, addiction, TransporterAutores:Ananth M., David Edward Komatsu, Hadjiargyrou M., Robison L.S., Thanos P.K.Fuentes:scopusChronic treatment and abstinence from methylphenidate exposure dose-dependently changes glucose metabolism in the rat brain
ArticleAbstract: Methylphenidate (MP) is extensively prescribed for attention deficit hyperactivity disorder (ADHD).Palabras claves:Brain Glucose Metabolism, FDG, imaging, methylphenidate, PetAutores:Blum K., David Edward Komatsu, Delis F., Fricke D., Hadjiargyrou M., Hamilton J., Martin C., Richer K., Sajjad M., Thanos P.K., Yao R.Fuentes:scopusCombined methylphenidate and fluoxetine treatment in adolescent rats significantly impairs weight gain with minimal effects on skeletal development
ArticleAbstract: Methylphenidate (MP) is frequently prescribed to treat Attention-Deficit/Hyperactivity Disorder (ADHPalabras claves:Fluoxetine, methylphenidate, RAT, Skeletal developmentAutores:Areikat N., Chirokikh A.A., Connor C., David Edward Komatsu, Duque E., Hadjiargyrou M., Jones R., Thanos P.K., Uddin S.M.Z.Fuentes:scopusBehavioral, Neurochemical and Developmental Effects of Chronic Oral Methylphenidate: A Review
ReviewAbstract: The majority of animal studies on methylphenidate (MP) use intraperitoneal (IP) injections, subcutanPalabras claves:ADHD, animal model, Behavior, dopamine, methylphenidate, neurochemistry, Psychostimulant, ritalinAutores:Ahmed R., Arnavut E., Badgaiyan R.D., Blum K., Carvalho A., David Edward Komatsu, Hadjiargyrou M., Lee W.X., Senior D., Thanos P.K.Fuentes:scopusBiocompatible customized 3D bone scaffolds treated with CRFP, an osteogenic peptide
ArticleAbstract: Background: Currently used synthetic bone graft substitutes (BGS) are either too weak to bear the prPalabras claves:3D Printing, ABS, Artificial bone, CRFP, MED610, Osteogenic peptide, ScaffoldsAutores:Anugu A., David Edward Komatsu, Kao I., Mustahsan V.M., Pentyala S.N.Fuentes:scopusBiomechanical properties of 3D-printed bone scaffolds are improved by treatment with CRFP
ArticleAbstract: Background: One of the major challenges in orthopedics is to develop implants that overcome currentPalabras claves:Autores:Carlos G. Helguero, David Edward Komatsu, Kao I., Mustahsan V.M., Parmar S., Pentyala S., Pentyala S.N., Pfail J.Fuentes:googlescopusAbstinence following intermittent methylphenidate exposure dose-dependently modifies brain glucose metabolism in the rat brain
ArticleAbstract: Methylphenidate (MP) is a psychostimulant chronically prescribed for the treatment of attention defiPalabras claves:Abstinence, addiction, brain function, FDG, Functional connectivity, glucose utilization, methylphenidate, microPET, PetAutores:Arnavut E., David Edward Komatsu, Hadjiargyrou M., Hamilton J., Sajjad M., Thanos P.K., Yao R.Fuentes:scopusAbstinence from Chronic Methylphenidate Exposure Modifies Cannabinoid Receptor 1 Levels in the Brain in a Dose-dependent Manner
ArticleAbstract: Introduction: Methylphenidate (MP) is a widely used psychostimulant prescribed for Attention DeficitPalabras claves:Attention Deficit Hyperactivity Disorder, Cannabinoid receptor 1, Endocannabinoid system, methylphenidate, Psychostimulant, ritalinAutores:Connor C., David Edward Komatsu, Hadjiargyrou M., Hamilton J., Robison L.S., Thanos P.K.Fuentes:scopus